AAA February 2012 – Page 4

Pfizer, Novartis, J&J pump $43m into Celladon

US-based biopharmaceutical company Celladon closed a $43 equity round on Wednesday led by Pfizer Ventures, the corporate venturing fund for pharmaceutical corporation Pfizer. Two other corporate venturing funds for pharma companies – Novartis Venture Funds, and Johnson & Johnson Development Corporation – also participated in the round, as did life science venture funds Hambrecht &… Continue reading Pfizer, Novartis, J&J pump $43m into Celladon